Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous total IgG in severe atopic dermatitis refractory to dupilumab
KCT0006092Phase 2Active, not recruiting
- Sponsor
- Ajou University Hospital
- Start
- Apr 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of autologous immunoglobulin in atopic dermatitis (AD), sponsored by Ajou University Hospital. Started Apr 2021; status: active, not recruiting.
02
Drugs
autologous immunoglobulin
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on KCT0006092.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0006092.